Sun Pharmaceutical Industries Ltd. closed 15.94% below its 52-week high of 1,960.20 rupees, which the company reached on ...

Sun Pharmaceutical Industries Ltd. closed 15.88% below its 52-week high of 1,960.20 rupees, which the company reached on September 30th.

CHENNAI: Shares of Sun Pharmaceutical Industries Ltd. are under investor scrutiny today following two significant ...

The company's current managing director, Dilip Shanghvi, will continue to chair the board as an executive director, Sun ...

Shares of Sun Pharma Advanced Research Company Ltd (SPARC) plunged nearly 20% on Wednesday on the NSE, after the company announced disappointing results from Phase 2 trials of its experimental drug, ...

The shares of Sun Pharma Advanced Research Company Limited (SPARC), a clinical-stage biopharmaceutical firm were trading at Rs 159.85 apiece on Wednesday. SPARC, the research division of Sun Pharma, ...

CHENNAI: Shares of India's largest drug maker Sun Pharmaceutical Industries fell almost 1% on main stock exchanges on Wednesday following the company's announcement of a disappointing trial ...

Melbourne Pharma Logo Mike Boehmer, Lead Pharmacist Robert Robinson, Non-Sterile Lab Manager Melbourne Pharma offers expert, ...

About Nasus Pharma Ltd. Based on its unique microsphere technology, Nasus Pharma is developing a number of intranasal powder products addressing acute emergency situations in the community such as ...

Sun Pharmaceutical Industries is discontinuing two trials of its drug candidate SCD-044 for moderate to severe psoriasis and atopic dermatitis, as they did not meet the primary endpoints.